Attached files
| file | filename |
|---|---|
| EX-3.4 - CERTIFICATE OF DESIGNATION - EVOLUTIONARY GENOMICS, INC. | fnam_ex34.htm |
| EX-10.13 - NOTICE OF TERMINATION - EVOLUTIONARY GENOMICS, INC. | fnam_ex10z13.htm |
| 10-K - ANNUAL REPORT - EVOLUTIONARY GENOMICS, INC. | fnam_10k.htm |
| EX-31.2 - CERTIFICATION - EVOLUTIONARY GENOMICS, INC. | fnam_ex31z2.htm |
| EX-32.1 - CERTIFICATION - EVOLUTIONARY GENOMICS, INC. | fnam_ex32z1.htm |
| EX-31.1 - CERTIFICATION - EVOLUTIONARY GENOMICS, INC. | fnam_ex31z1.htm |
EXHIBIT 32.2
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Annual Report of Evolutionary Genomics, Inc. (the "Company") on Form 10-K for the year ended December 31, 2019, as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, Steve B Warnecke, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. section1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to the best of my knowledge:
(1) The Report fully complies with the requirements of Section 13(a) or 15(d), as applicable, of the Securities Exchange Act of 1934; and
(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
BY: | /s/ Steve B Warnecke |
| Steve B Warnecke |
| Chief Financial Officer |
| (principal financial officer) |
| March 30, 2020 |